Charles River Laboratory executives said they continue to expect the North American research model business volume to decline, and expenses for academic and government customers are limited by the US National Institutes of Health's flat budget and the slow funding approval process.

Charles River Laboratory executives said they continue to expect the North American research model business volume to decline, and expenses for academic and government customers are limited by the US National Institutes of Health's flat budget and the slow funding approval process.